Granules shares gain over 5% on U.S. FDA nod for ADHD generic capsules
Granules India receives FDA approval for generic ADHD drug, expanding portfolio and reinforcing presence in the treatment space
Granules India receives FDA approval for generic ADHD drug, expanding portfolio and reinforcing presence in the treatment space
What's Your Reaction?
